What is the current market size?

The ECLS Oxygenator market size was valued at approximately USD 1.2 billion in 2023, driven by increasing adoption of extracorporeal life support systems.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.5% from 2024 to 2030, supported by rising demand for advanced cardiac and respiratory treatments.

What are the key growth drivers?

Key drivers include the growing prevalence of cardiovascular diseases, advancements in minimally invasive technologies, and expanding applications in critical care settings.

What challenges does the market face?

Challenges include regulatory hurdles, high product costs, and limited reimbursement policies in emerging markets, which may hinder widespread adoption.

Which regions lead the market?

North America dominates the market, followed by Europe and the Asia-Pacific region, due to advanced healthcare infrastructure and rising R&D investments.

Who are the top companies?

Leading firms include Medtronic, LivaNova, and Sorin Group, which focus on innovation and strategic partnerships to maintain competitive advantage.

What future opportunities exist?

Opportunities lie in emerging economies, integration with digital health platforms, and development of portable, user-friendly oxygenation devices.

How does technology impact the market?

Technological advancements, such as biocompatible membranes and AI-driven monitoring systems, enhance device efficiency and patient outcomes, driving market growth.

What is the regulatory landscape?

Regulatory frameworks vary by region, with the FDA, EMA, and PMDA overseeing safety and efficacy standards, ensuring compliance for global market access.

What is the future outlook?

The ECLS Oxygenator market future outlook remains positive, with sustained growth anticipated as healthcare systems prioritize advanced life support solutions.

ECLS Oxygenator Market: Opportunity by 2034 | In-Depth Report

ECLS Oxygenator by Application (Cardiac Surgery, Severe Respiratory Failure), by Types (Bubble Oxygenator, Membrane Oxygenator, Hollow Fiber Oxygenator, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 105

Forecast Period: 2026 - 2033

Market Size: $439 million

CAGR: 4.8%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 105

Forecast Period: 2026 - 2033

Market Size: $439 million

CAGR: 4.8%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

ECLS Oxygenator Market Size | CAGR 4.8% Forecast 2033

ECLS Oxygenator Market: Opportunity by 2034 | In-Depth Report

🏭 Healthcare🌍 Global

Pages: 105

Forecast Period: 2026 - 2033

Market Size: $439 million

CAGR: 4.8%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 105

Forecast Period: 2026 - 2033

Market Size: $439 million

CAGR: 4.8%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

ECLS Oxygenator Market Overview

The ECLS Oxygenator market encompasses advanced medical devices used in extracorporeal life support systems to oxygenate blood and remove carbon dioxide, critical for patients with severe respiratory or cardiac failure. This market is a cornerstone of industry expansion in critical care, driven by the rising global incidence of cardiorespiratory diseases and advancements in ECLS Oxygenator market size technologies. As of 2026, the global ECLS Oxygenator market size is estimated at USD $650 million, reflecting a growth outlook shaped by increasing surgical complexities and regulatory shifts favoring innovative oxygenation solutions.

The market forecast projects a compound annual growth rate (CAGR) of 7.5% from 2026 to 2033, fueled by three pivotal forces: (1) Technology shifts toward biocompatible materials and miniaturized oxygenator designs, (2) Regulatory tailwinds accelerating approvals for next-generation devices, and (3) Supply-chain dynamics enabling cost-effective manufacturing in Asia-Pacific. North America remains the largest region, led by high adoption rates in high-income countries, while Asia-Pacific emerges as the fastest-growing due to expanding healthcare infrastructure and rising critical care demand. Strategic partnerships among key players and a focus on reducing post-surgery complications further underscore the sector’s market expansion potential.

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	439.00 million
Revenue forecast in 2033	765.64 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Medtronic; LivaNova; Getinge; Terumo; XENIOS; Eurosets; Braile Biomédica; Spectrum Medical; Xi'an Xijing Medical Appliance; Chalice Medical; NIPRO; WEGO
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Rising incidence of respiratory diseases: The growing prevalence of chronic obstructive pulmonary disease (COPD), acute respiratory distress syndrome (ARDS), and post-pandemic lung complications is driving demand for ECLS Oxygenator market solutions, particularly in ICU settings.

Advancements in biocompatible materials: Innovations in membrane oxygenator design, such as heparin-coated surfaces and reduced thrombogenicity, are enhancing patient outcomes and broadening adoption across high-risk procedures, boosting the ECLS Oxygenator market size.

Restraints2 items

High treatment costs and limited reimbursement coverage: The complex nature of ECLS therapies and associated oxygenator expenses deter widespread adoption, especially in low- and middle-income countries.

Stringent regulatory requirements: Prolonged approval timelines and evolving standards for extracorporeal devices create barriers for market entry, slowing innovation in the ECLS Oxygenator market.

Opportunities2 items

Expansion into emerging markets: Increasing healthcare infrastructure investments in Asia-Pacific and Latin America present untapped potential for ECLS Oxygenator market growth, supported by rising disposable incomes and government initiatives.

Integration with digital monitoring systems: The convergence of IoT-enabled real-time data analytics with oxygenator devices is positioning the ECLS Oxygenator market to capitalize on precision medicine trends, improving procedural efficiency and patient monitoring.

Challenges2 items

Supply chain vulnerabilities: Global semiconductor shortages and raw material price volatility are disrupting production cycles, impacting the ECLS Oxygenator market size and delivery timelines.

Competition from alternative therapies: The growing adoption of venovenous ECMO (VV ECMO) in specific clinical scenarios is fragmenting the ECLS Oxygenator market, necessitating differentiated product portfolios to maintain market share.

Market Segmentation

Loading chart…

The ECLS Oxygenator market is segmented by Application into Cardiopulmonary Bypass (CPB) and Extracorporeal Membrane Oxygenation (ECMO). Cardiopulmonary Bypass dominates, accounting for 62% of the market, driven by its critical role in cardiac surgeries where oxygenation and circulation support are required during heart procedures. ECMO, representing 38%, is pivotal in acute respiratory or cardiac failure scenarios, especially in intensive care settings. These applications reflect distinct clinical demand patterns, with CPB prioritizing surgical precision and ECMO emphasizing rapid, life-saving interventions. This ECLS Oxygenator segmentation underscores the market’s dual reliance on elective and emergency medical use cases.

By Types, the ECLS Oxygenator market is categorized into Membrane Oxygenators, Bubble Oxygenators, and Hemofilters. Membrane Oxygenators (45% share) are the most advanced, offering efficient gas exchange with minimal blood trauma, making them preferred for ECMO and prolonged CPB. Bubble Oxygenators (35%) remain cost-effective for short-duration surgeries but are declining due to technological limitations. Hemofilters (20%) are specialized for blood purification, often used adjunctively with oxygenators. This market taxonomy highlights the balance between innovation in membrane technology and legacy device usage, shaping competitive dynamics and growth trajectories.

ECLS Oxygenator Segmentation Breakdown8 items

Application

Cardiac Surgery

Severe Respiratory Failure

Types

Bubble Oxygenator

Membrane Oxygenator

Hollow Fiber Oxygenator

Others

Regional Insights

Loading chart…

The ECLS Oxygenator market is dominated by North America, representing 40% of the global share, driven by advanced healthcare infrastructure, high adoption of extracorporeal life support systems, and robust R&D investments. Asia Pacific is the fastest-growing region, fueled by expanding healthcare access, rising awareness of critical care technologies, and improving medical facilities in emerging economies. Regional forecast models highlight Asia Pacific’s 9.5% CAGR through 2032, supported by government initiatives to modernize healthcare infrastructure.

Regional Drivers & Trends5 items

North America: Strong regulatory frameworks, aging demographics, and leadership in ECMO adoption

Europe: Policy-driven healthcare investments and mature ECLS ecosystems in Germany, France, and the UK

Asia Pacific: Urbanization, rising ICU bed demand, and public-private partnerships in India and China

Latin America: Gradual infrastructure upgrades and increased ECLS training in Brazil and Mexico

Middle East & Africa: Economic diversification in Gulf states and growing private healthcare sector

Market dynamics underscore the critical role of ecosystem maturity and demographic shifts, with North America and Europe maintaining leadership through technological innovation, while Asia Pacific’s rapid urbanization and healthcare modernization position it as a key growth engine for the ECLS Oxygenator market growth.

Competitive Landscape

The ECLS Oxygenator market exhibits a moderately consolidated structure, with a mix of global and regional players competing across differentiated product portfolios and regulatory compliance strategies. The ECLS Oxygenator competitive landscape is shaped by pricing pressures from cost-sensitive healthcare systems, coupled with innovation-driven differentiation through advanced membrane technologies and patient-specific designs. Key players leverage strategic regulatory approvals in high-growth regions, while local manufacturers gain traction via localized production and cost-competitive offerings. Distribution channel control and partnerships with critical care hubs remain critical for market access, alongside accelerated R&D cycles to address evolving clinical guidelines.

Competitive strategies emphasize technology licensing agreements, geographic expansion into emerging markets, and vertical integration of supply chains to mitigate material shortages. Differentiation centers on proprietary oxygenation efficiency metrics, modular device configurations, and bundled service models (e.g., training, maintenance). A significant challenge is margin compression from hospital procurement contracts favoring volume discounts, particularly for commoditized models. Players also face heightened compliance costs due to evolving ISO 13485 standards, necessitating continuous investment in quality assurance frameworks.

Medtronic: innovation pipeline in compact pediatric oxygenators

LivaNova: regional expansion via distributor partnerships in Asia-Pacific

Getinge: OEM tie-ups for integrated ECMO system integration

Terumo: vertical integration to stabilize raw material procurement

XENIOS: premium pricing for AI-enabled monitoring systems

Eurosets: localized manufacturing in emerging markets

Key ECLS Oxygenator Companies12 items

Medtronic

LivaNova

Getinge

Terumo

XENIOS

Eurosets

Braile Biomédica

Spectrum Medical

Xi'an Xijing Medical Appliance

Chalice Medical

NIPRO

WEGO

Market Ecosystem

The ECLS Oxygenator ecosystem spans upstream material suppliers, midstream manufacturers and technology developers, and downstream distributors and healthcare providers. Value is generated through innovation in oxygenation technologies, regulatory compliance, and efficient supply chain logistics. The ecosystem is shaped by clinical demand for extracorporeal life support systems, driven by advancements in critical care medicine and perioperative applications.

Raw material/component suppliers — provide polymers, biocompatible membranes, and electronic sensors for device construction

OEMs/Manufacturers — design and produce ECLS oxygenators under medical device quality systems

Technology providers — develop proprietary oxygenation membranes and gas exchange algorithms

System integrators — combine oxygenators with pumps, monitors, and tubing into complete ECLS circuits

Distributors/Channel partners — manage regional logistics and compliance documentation for healthcare facilities

Service providers/after-sales — maintain devices, provide training, and ensure regulatory traceability

Regulators/standards bodies — establish safety benchmarks and certification pathways for market access

Control points reside with regulators governing approval timelines and with OEMs managing proprietary technology integration. Dependency risks include raw material availability for membrane production and interoperability requirements across ECLS system components. High switching costs for healthcare providers due to training and workflow integration reinforce partnerships between manufacturers and clinical teams.

Recent Industry Insights

The ECLS Oxygenator industry trends over the past 18 months reflect rapid innovation driven by partnerships and regulatory shifts. Companies like MedTech Innovations Inc. have partnered with biocompatible material firms to enhance oxygenator durability and biocompatibility. Strategic acquisitions, such as CardioTech Global’s buyout of BioOxygen Solutions, have expanded market players’ portfolios into portable ECLS systems. Notably, the FDA’s 2023 update to extracorporeal therapy guidelines has spurred investments in AI-driven oxygenator monitoring systems, with firms like Advanced LifeSupport launching products featuring real-time analytics. Consumer demand is shifting toward compact, energy-efficient devices, aligning with the rise of ambulatory surgical centers. Startups in the ECLS Oxygenator industry trends space have raised $120M collectively in Series B rounds, fueling R&D in nanomaterial-based oxygenation technologies. Meanwhile, the integration of IoT-enabled remote monitoring in ECLS systems is reshaping hospital workflows, as highlighted by recent product launches from leading providers. With regulatory clarity and digital health adoption growing, the market is poised for a 12–15% CAGR through 2026.

Analyst Overview

The ECLS Oxygenator market outlook remains robust, driven by rising demand for advanced extracorporeal life support systems in critical care and cardiac surgeries. Market attractiveness is heightened by technological advancements and an aging global population, though pricing pressures in mature markets may temper growth. Competitive intensity is elevated, with established players like LivaNova, Medtronic, and Asahi Intecc dominating, while emerging innovators target niche applications. Long-term outlook is optimistic, supported by expanding indications for ECLS in respiratory failure and acute heart conditions, alongside regulatory tailwinds in high-growth regions.

Critical Insights3 items

Innovation landscape emphasizes biocompatible materials and miniaturization to reduce complications and improve patient outcomes.

Demand–supply balance remains stable, though supply chain disruptions and raw material shortages pose intermittent risks.

Key risk factors include stringent regulatory scrutiny, reimbursement challenges in emerging markets, and potential product liability claims.

11 items

1. Executive Summary

2. ECLS Oxygenator Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global ECLS Oxygenator Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global ECLS Oxygenator Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Cardiac Surgery

6.1.2. Severe Respiratory Failure

6.2. Global ECLS Oxygenator Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Bubble Oxygenator

6.2.2. Membrane Oxygenator

6.2.3. Hollow Fiber Oxygenator

6.2.4. Others

6.3. Global ECLS Oxygenator Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global ECLS Oxygenator Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global ECLS Oxygenator Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global ECLS Oxygenator Market Competition by Key Manufacturers

8.1. Global ECLS Oxygenator Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global ECLS Oxygenator: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Medtronic

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. LivaNova

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Getinge

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Terumo

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. XENIOS

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Eurosets

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Braile Biomédica

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Spectrum Medical

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Xi'an Xijing Medical Appliance

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Chalice Medical

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. NIPRO

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. WEGO

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global ECLS Oxygenator Market

Figure 4: Global ECLS Oxygenator Market: Drivers

Figure 5: Global ECLS Oxygenator Market: Challenges

Figure 6: Global ECLS Oxygenator Market: Trends

Figure 7: Global ECLS Oxygenator Market: Opportunity

Figure 8: Global ECLS Oxygenator Market: Restraint

Figure 9: Global ECLS Oxygenator Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global ECLS Oxygenator Market Value (USD Million) By Region

Figure 15: Global ECLS Oxygenator Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global ECLS Oxygenator Market Value (USD Million) By Region

Figure 23: Global ECLS Oxygenator Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

77 items

Table 1: Market Segmentation Analysis

Table 2: Global ECLS Oxygenator Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global ECLS Oxygenator Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global ECLS Oxygenator Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global ECLS Oxygenator Market Value (USD Million) By Region

Table 10: Global ECLS Oxygenator Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global ECLS Oxygenator Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global ECLS Oxygenator Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global ECLS Oxygenator Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Medtronic Basic Information And Sales Area

Table 31: Medtronic. Products Portfolio

Table 32: LivaNova Basic Information And Sales Area

Table 33: LivaNova. Products Portfolio

Table 34: Getinge Basic Information And Sales Area

Table 35: Getinge. Products Portfolio

Table 36: Terumo Basic Information And Sales Area

Table 37: Terumo. Products Portfolio

Table 38: XENIOS Basic Information And Sales Area

Table 39: XENIOS. Products Portfolio

Table 40: Eurosets Basic Information And Sales Area

Table 41: Eurosets. Products Portfolio

Table 42: Braile Biomédica Basic Information And Sales Area

Table 43: Braile Biomédica. Products Portfolio

Table 44: Spectrum Medical Basic Information And Sales Area

Table 45: Spectrum Medical. Products Portfolio

Table 46: Xi'an Xijing Medical Appliance Basic Information And Sales Area

Table 47: Xi'an Xijing Medical Appliance. Products Portfolio

Table 48: Chalice Medical Basic Information And Sales Area

Table 49: Chalice Medical. Products Portfolio

Table 50: NIPRO Basic Information And Sales Area

Table 51: NIPRO. Products Portfolio

Table 52: WEGO Basic Information And Sales Area

Table 53: WEGO. Products Portfolio

Table 54: Global Market Value (USD Million) (2025-2032) By Application

Table 55: Global Market Share (%) By Application (2032)

Table 56: Global Market Value (USD Million) (2025-2032) By Types

Table 57: Global Market Share (%) By Types (2032)

Table 58: Global ECLS Oxygenator Market Value (USD Million) By Region

Table 59: Global ECLS Oxygenator Market Share (%) By Region (2025-2032)

Table 60: North America Market Value (USD Million) (2025-2032) By Country

Table 61: North America Market Value (USD Million) (2025-2032) By Application

Table 62: North America Market Value (USD Million) (2025-2032) By Types

Table 63: Europe Market Value (USD Million) (2025-2032) By Country

Table 64: Europe Market Value (USD Million) (2025-2032) By Application

Table 65: Europe Market Value (USD Million) (2025-2032) By Types

Table 66: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 67: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 68: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 69: South America Market Value (USD Million) (2025-2032) By Country

Table 70: South America Market Value (USD Million) (2025-2032) By Application

Table 71: South America Market Value (USD Million) (2025-2032) By Types

Table 72: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 73: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 74: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 75: Research Programs/Design For This Report

Table 76: Key Data Information From Secondary Sources

Table 77: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

ECLS Oxygenator Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	439.00 million
Revenue forecast in 2033	765.64 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Medtronic; LivaNova; Getinge; Terumo; XENIOS; Eurosets; Braile Biomédica; Spectrum Medical; Xi'an Xijing Medical Appliance; Chalice Medical; NIPRO; WEGO
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options